Mimpara

Medicinal product

(Invented) name

Mimpara

Active substance (s)

Cinakalcetas

Strength

2,5 mg

Pharmaceutical form

granulės atidaromose kapsulėse

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H05BX01, Cinacalcet

Marketing authorisation holder

Amgen Europe B.V., Nyderlandai

Date of authorisation

2004-10-22

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Granules in capsules for opening	1 vnt.
Cinakalcetas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
97832	83927	1083927	buteliukas	N30		Receptinis	EU/1/04/292/014	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2004-10-22	Registruotas